Repligen Financial Statements From 2010 to 2022

RGEN
 Stock
  

USD 191.06  2.29  1.21%   

Repligen financial statements provide useful quarterly and yearly information to potential Repligen Cp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Repligen financial statements helps investors assess Repligen's valuation, profitability, and current liquidity needs.
Repligen Cp does not presently have any trending fundamental ratios for analysis.
.
  
Check Repligen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Repligen main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Repligen financial statements analysis is a perfect complement when working with Repligen Valuation or Volatility modules. It can also supplement Repligen's financial leverage analysis and stock options assessment as well as various Repligen Technical models . Additionally, take a look at the analysis of Repligen Correlation against competitors.

Repligen Short Ratio Analysis

Repligen's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Short Ratio 
 = 
Short Interest 
Average Trading Volume 
More About Short Ratio | All Equity Analysis

Current Repligen Short Ratio

    
  7.31 X  
Most of Repligen's fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Repligen Cp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
Compare to competition

Based on the latest financial disclosure, Repligen Cp has a Short Ratio of 7.31 times. This is 87.44% higher than that of the Healthcare sector and 80.05% higher than that of the Medical Instruments & Supplies industry. The short ratio for all United States stocks is 82.75% lower than that of the firm.

Repligen Cp Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Repligen's current stock value. Our valuation model uses many indicators to compare Repligen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Repligen competition to find correlations between indicators driving Repligen's intrinsic value. More Info.
Repligen Cp is currently regarded as top stock in earnings per share category among related companies. It is currently regarded as top stock in price to earnings to growth category among related companies producing about  2.07  of Price to Earnings To Growth per Earnings Per Share. . Comparative valuation analysis is a catch-all model that can be used if you cannot value Repligen by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Repligen's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Repligen's earnings, one of the primary drivers of an investment's value.

About Repligen Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Repligen income statement, its balance sheet, and the statement of cash flows. Repligen investors use historical funamental indicators, such as Repligen's revenue or net income, to determine how well the company is positioned to perform in the future. Although Repligen investors may use each financial statement separately, they are all related. The changes in Repligen's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Repligen's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Repligen Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Repligen. Please read more on our technical analysis and fundamental analysis pages.
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham, Massachusetts. Repligen operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 1852 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Repligen without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Center Now

   

Portfolio Center

All portfolio management and optimization tools to improve performance of your portfolios
All  Next Launch Module

Currently Active Assets on Macroaxis

Additionally, take a look at the analysis of Repligen Correlation against competitors. Note that the Repligen Cp information on this page should be used as a complementary analysis to other Repligen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try CEO Directory module to screen CEOs from public companies around the world.

Complementary Tools for Repligen Stock analysis

When running Repligen Cp price analysis, check to measure Repligen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repligen is operating at the current time. Most of Repligen's value examination focuses on studying past and present price action to predict the probability of Repligen's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Repligen's price. Additionally, you may evaluate how the addition of Repligen to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Is Repligen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repligen. If investors know Repligen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repligen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Repligen Cp is measured differently than its book value, which is the value of Repligen that is recorded on the company's balance sheet. Investors also form their own opinion of Repligen's value that differs from its market value or its book value, called intrinsic value, which is Repligen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repligen's market value can be influenced by many factors that don't directly affect Repligen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Repligen's value and its price as these two are different measures arrived at by different means. Investors typically determine Repligen value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repligen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.